Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Sieper J, Emery P, Keystone EC, Schiff MH, Mease P, van Riel PL, Fleischmann R, Weisman MH, Weinblatt ME.

Ann Rheum Dis. 2007 Nov;66 Suppl 3:iii2-22. Review. No abstract available. Erratum in: Ann Rheum Dis. 2008 Feb;67(2):280.

2.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006.

Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Emery P, Keystone EC, Schiff MH, van Riel PL, Weinblatt ME, Weisman MH.

Ann Rheum Dis. 2006 Nov;65 Suppl 3:iii2-15. No abstract available.

3.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008.

Furst DE, Keystone EC, Kirkham B, Kavanaugh A, Fleischmann R, Mease P, Breedveld FC, Smolen JS, Kalden JR, Burmester GR, Braun J, Emery P, Winthrop K, Bresnihan B, De Benedetti F, Dörner T, Gibofsky A, Schiff MH, Sieper J, Singer N, Van Riel PL, Weinblatt ME, Weisman MH.

Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii2-25. doi: 10.1136/ard.2008.100834. No abstract available. Erratum in: Ann Rheum Dis. 2009 Mar;68(3):452. Kavanaugh, A [added].

PMID:
19022808
4.

[Biologicals in the treatment of rheumatic diseases].

Scherer HU, Burmester GR.

Dtsch Med Wochenschr. 2006 Oct 13;131(41):2279-85. Review. German. No abstract available.

PMID:
17036270
5.

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.

Fernández-Nebro A, Tomero E, Ortiz-Santamaría V, Castro MC, Olivé A, de Haro M, Portales RG, González-Mari MV, Laffón A, García-Vicuña R.

Am J Med. 2005 May;118(5):552-6. No abstract available. Erratum in: Am J Med. 2006 Feb;119(2):191. Garcia-Vicuna, Rosa [corrected to Portales, Rosa García ].

PMID:
15866260
6.

Putting new disease-modifying antirheumatic drugs into perspective.

Saseen JJ.

Pharmacotherapy. 2007 Dec;27(12):1609-10. No abstract available.

PMID:
18041880
7.

Once-a-month injection approved to treat three types of arthritis.

Thompson CA.

Am J Health Syst Pharm. 2009 Jun 1;66(11):968. doi: 10.2146/news090045. No abstract available.

PMID:
19451600
8.

Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?

Goodemote P, Jamieson B, Hoffman R.

J Fam Pract. 2007 Nov;56(11):933-4, 937. No abstract available.

PMID:
17976342
9.

[Autoimmune aspects of treatment with TNF-alpha inhibitors].

Kolarz B, Targońska-Stepniak B, Darmochwał-Kolarz D, Majdan M.

Postepy Hig Med Dosw (Online). 2007 Aug 28;61:478-84. Review. Polish.

10.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011.

Furst DE, Keystone EC, Braun J, Breedveld FC, Burmester GR, De Benedetti F, Dörner T, Emery P, Fleischmann R, Gibofsky A, Kalden JR, Kavanaugh A, Kirkham B, Mease P, Sieper J, Singer NG, Smolen JS, Van Riel PL, Weisman MH, Winthrop K.

Ann Rheum Dis. 2012 Apr;71 Suppl 2:i2-45. doi: 10.1136/annrheumdis-2011-201036. No abstract available.

PMID:
22460137
11.

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002).

Furst DE, Breedveld FC, Kalden JR, Smolen JS, Antoni CE, Bijlsma JW, Burmester GR, Cronstein B, Keystone EC, Kavanaugh A, Klareskog L.

Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii2-7. Review. No abstract available.

12.

Experiences on the use of biological drugs in psoriatic arthritis-associated amyloidosis.

Immonen K, Kauppi M, Hakala M.

Scand J Rheumatol. 2011 May;40(3):236-8. doi: 10.3109/03009742.2010.530294. Epub 2011 Jan 13. No abstract available.

PMID:
21231814
13.

Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.

Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Bijlsma JW, Dougados M, Emery P, Keystone EC, Klareskog L, Mease PJ.

Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv2-14. Review. No abstract available.

15.

Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.

Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU.

Arthritis Rheum. 2012 Jul;64(7):2068-77. doi: 10.1002/art.34382.

16.

[Revision of the recommendations of the Commission on Pharmacotherapy of the German society for Rheumatology. Therapy with tumour necrosis factor blockers for inflammatory rheumatic illnesses].

Manger B, Michels H, Nüsslein HG, Schneider M, Sieper J; Kommission Pharmakotherapie der DGRh.

Z Rheumatol. 2007 Feb;66(1):72-5. German.

PMID:
17221253
17.

The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.

Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S.

Int J Rheum Dis. 2009 Jul;12(2):118-24. doi: 10.1111/j.1756-185X.2009.01393.x.

PMID:
20374328
18.

Emerging therapies in juvenile rheumatoid/idiopathic arthritis.

Passo M.

Curr Probl Pediatr Adolesc Health Care. 2006 Mar;36(3):97-103. Review. No abstract available.

PMID:
16473286
19.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009.

Furst DE, Keystone EC, Fleischmann R, Mease P, Breedveld FC, Smolen JS, Kalden JR, Braun J, Bresnihan B, Burmester GR, De Benedetti F, Dörner T, Emery P, Gibofsky A, Kavanaugh A, Kirkham B, Schiff MH, Sieper J, Singer N, Van Riel PL, Weinblatt ME, Weisman MH, Winthrop K.

Ann Rheum Dis. 2010 Jan;69 Suppl 1:i2-29. doi: 10.1136/ard.2009.123885. No abstract available. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
19995740
20.

[Non-TNF biologicals in the therapeutic strategy for rheumatoid arthritis].

Wollenhaupt J, Krüger K.

Z Rheumatol. 2010 Sep;69(7):618-25. doi: 10.1007/s00393-009-0532-5. German.

PMID:
20703488
Items per page

Supplemental Content

Write to the Help Desk